Key Market Indicators
Italian sales of antirheumatic medicines are predicted to drop from $159 million this year to around $103 million by 2026. Since 2016, the market in Italy has decreased by almost 6% each year. The country came in fifth place in 2021, behind Canada with $159 million, Germany, Spain and Canada in second, third and fourth place respectively.
